Regulation and Clinical Implication of Arginine Vasopressin in Patients with Severe Aortic Stenosis Referred to Trans-Catheter Aortic Valve Implantation

Background and objectives: Plasma arginine vasopressin (P-AVP) is regulated by the non-osmotic pathway in patients with heart failure (HF) and reduced ejection fraction. However, the regulation of P-AVP in patients with severe aortic stenosis (AS) remains unknown. Materials and Methods: Consecutive...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuwahara, Hiroyuki, Imamura, Teruhiko, Sobajima, Mitsuo, Ueno, Hiroshi, Kinugawa, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230582/
https://www.ncbi.nlm.nih.gov/pubmed/32268535
http://dx.doi.org/10.3390/medicina56040165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230582/
https://www.ncbi.nlm.nih.gov/pubmed/32268535
http://dx.doi.org/10.3390/medicina56040165

Ejemplares similares